¼¼¹Ì³ª/Çà»ç

> Á¤º¸¼¾ÅÍ > ¼¼¹Ì³ª/Çà»ç

Á¦¸ñ 2020³â 11¿ù 18ÀÏ »ý¹°Á¤º¸ÇÐ ¼¼¹Ì³ª
ÀÛ¼ºÀÚ °ü¸®ÀÚ ÀÛ¼ºÀÏ 2020-11-12
¼­¿ï´ëÇб³ »ý¹°Á¤º¸ÇÐ Çùµ¿°úÁ¤ ÁÖÃÖ·Î ¼¼¹Ì³ª¸¦ ¾Æ·¡¿Í °°ÀÌ ¿­°íÀÚ ÇÏ¿À´Ï ¸¹Àº Âü¿© ¹Ù¶ø´Ï´Ù.
¼¼¹Ì³ª´Â ZoomÀ» ÅëÇÑ ¿Â¶óÀÎ °­ÀÇ·Î ¿¹Á¤µÇ¾î ÀÖÀ¸¸ç °­ÀÇ¿¡ Âü¿©ÇÏ°íÀÚ ÇϽô ºÐ²²¼­´Â¡¡mari911@snu.ac.kr·Î ¸ÞÀÏ ÁÖ½Ã¸é °­ÀÇ ¸µÅ© Àü´Þµå¸®µµ·Ï ÇÏ°Ú½À´Ï´Ù.¡¡

ÀϽÃ:¡¡¡¡2020³â 11¿ù 18ÀÏ¡¡¼ö¿äÀÏ ¿ÀÀü 11½Ã
¿¬»ç:¡¡¡¡³²±ÃÁ¤Çö ¿¬»ç´Ô¡¡(SK Telecom)

Title:¡¡Clinical Applications of Cell-free DNA Analysis

Abstract
This talk will introduce the origin of cell-free DNA (cfDNA) of human and the features of cfDNA sequencing data in the beginning. There are mainly two clinical applications of the cfDNA sequencing analysis: liquid biopsy for cancer patient and prenatal diagnosis. The technical and commercial aspects of the two applications will be overviewed in general. Also related commercial projects will be introduced that I had conducted. Brief reviews on the recent trends in cfDNA analysis technologies are followed.